Beta Bionics(BBNX)
IRVINE, CABiotechnology
Focus: Beta Bionics is a public biotech company focused on artificial pancreas technology, specifically the iLet Bionic Pancreas System for diabetes management. The company is in early commercialization phase with a small but growing footprint (1-50 employees as of data collection, now actively scaling).
Profile data last refreshed 2h ago · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Employees
1-50
Open Jobs
24+7 this month
Growing — net +7 jobs in 30d
11 jobs added vs 4 removed. Steady team buildout.
Should You Work at Beta Bionics?
AI assessmentBest for early-stage growth-focused professionals willing to accept pre-profitability volatility in exchange for equity upside and pioneering medical device-AI work in diabetes.
Why Work Here
- Riding a commercial inflection point: FY 2025 revenue jumped 442% YoY ($12M → $65M), signaling successful market entry for the iLet system with 12 commercial roles currently open.
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$65M
Pipeline & Clinical Trials
Help build intelligence for Beta Bionics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.